Green Cross Corporation (006280.KS)

118,700.00 -1,500.00 (-1.25%) At close: 03:30PM KST

Green Cross Corporation

107, Ihyeon-ro 30beon-gil
Giheung-gu
Yongin-Si
South Korea
82 3 1260 9300
https://www.globalgreencross.com

Sector(s): Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Full-time employees: 2,126

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Il-Sup Huh Ph.D.	Chairman & CEO	N/A	N/A	1954
Mr. Eun-Cheol Hur	Pres & Director	N/A	N/A	1972
Mr. Min-Taek Lee	Sr. Managing Director of Sales	N/A	N/A	1963
Mr. Young Sup Huh	Exec. VP	N/A	N/A	1941
Mr. In-Jae Lee	Sr. MD & Director	N/A	N/A	1963
Mr. Pyung-Ju Jang	Sr. Managing Director of PR	N/A	N/A	1962
Ms. Hwi-Jung Ji	Sr. Managing Director of R&D	N/A	N/A	1959
Mr. Jong-Ho Noh	Sr. Managing Director of Planning	N/A	N/A	1959
Mr. Kim Jin	Sr. Managing Director of R&D	N/A	N/A	1964
Mr. Dong-Ho Ahn	Managing Director of R&D	N/A	N/A	1959

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in KRW.

Description

Green Cross Corporation, a biopharmaceutical company, develops drugs and vaccines in South Korea. The company provides plasma derivatives, including albumin, immunoglobulin, and antithrombin; and vaccines for hepatitis-B, Hantavirus hemorrhagic fever, influenza, flu, and varicella. It also offers prescription drugs for the bleeding symptom control and hemostasis for persons with hemophilia A; prevention and treatment of bleeding episodes induced by hemophilia A and post-operative treatment; and treatment of neutropenia, hunter syndrome, and liver cancer, as well as treatment of anti-inflammation, pain relief, and osteoarthritis. In addition, the company provides over the counter drugs. It also exports its products to approximately 50 countries. The company has a licensing and collaboration agreement with Tottori University for development of GM1 gangliosidosis chaperone therapy. The company was formerly known as Sudo Microorganism Medical Supplies Company and changed its name to Green Cross Corporation in 1971. Green Cross Corporation was founded in 1967 and is headquartered in Yongin-si, South Korea. Green Cross Corporation is a subsidiary of Green Cross Holdings Corporation.

Corporate governance

Green Cross Corporation’s ISS governance QualityScore as of 1 February 2023 is 10. The pillar scores are Audit: 9; Board: 10; Shareholder rights: 6; Compensation: 9.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.